Correlation Between Becle Sab and Allovir

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Becle Sab and Allovir at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Becle Sab and Allovir into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Becle Sab DE and Allovir, you can compare the effects of market volatilities on Becle Sab and Allovir and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Becle Sab with a short position of Allovir. Check out your portfolio center. Please also check ongoing floating volatility patterns of Becle Sab and Allovir.

Diversification Opportunities for Becle Sab and Allovir

-0.42
  Correlation Coefficient

Very good diversification

The 3 months correlation between Becle and Allovir is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Becle Sab DE and Allovir in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allovir and Becle Sab is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Becle Sab DE are associated (or correlated) with Allovir. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allovir has no effect on the direction of Becle Sab i.e., Becle Sab and Allovir go up and down completely randomly.

Pair Corralation between Becle Sab and Allovir

Assuming the 90 days horizon Becle Sab DE is expected to generate 0.79 times more return on investment than Allovir. However, Becle Sab DE is 1.27 times less risky than Allovir. It trades about 0.02 of its potential returns per unit of risk. Allovir is currently generating about -0.03 per unit of risk. If you would invest  245.00  in Becle Sab DE on August 29, 2022 and sell it today you would lose (12.00)  from holding Becle Sab DE or give up 4.9% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.8%
ValuesDaily Returns

Becle Sab DE  vs.  Allovir

 Performance (%) 
       Timeline  
Becle Sab DE 
Becle Performance
3 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Becle Sab DE are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak essential indicators, Becle Sab exhibited solid returns over the last few months and may actually be approaching a breakup point.

Becle Price Channel

Allovir 
Allovir Performance
2 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Allovir are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Allovir may actually be approaching a critical reversion point that can send shares even higher in December 2022.

Allovir Price Channel

Becle Sab and Allovir Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Becle Sab and Allovir

The main advantage of trading using opposite Becle Sab and Allovir positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Becle Sab position performs unexpectedly, Allovir can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will offset losses from the drop in Allovir's long position.
Becle Sab vs. Brown Forman
Becle Sab vs. Constellation Brands
Becle Sab vs. Canterbury Park Hl
The idea behind Becle Sab DE and Allovir pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Allovir vs. Regeneron Pharmaceuticals
Allovir vs. Vertex Pharmaceutic
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go